- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00476905
Spectral Diagnosis of Cutaneous Malignancy
Study Overview
Detailed Description
The spectral-diagnosis probe being used in this study uses dim pulses of light to identify features of tissue that may be related to the status of skin cancer. The probe is shaped like a catheter, and it has a camera on the end, which takes pictures of the skin.
If you agree to take part in this study, you will be asked questions about your age, race, smoking status, and the status of any diseases you may have (such as diabetes, connective tissue disease, and infectious disease). It should take about 5 minutes to answer these questions.
The study doctor will then decide which of your lesions are suitable for imaging by the probe. If necessary, any hair on or around the lesion(s) will be shaved or trimmed. The area(s) of skin being imaged will be cleaned with rubbing alcohol.
As part of your exam, the study doctor will use the probe to measure the selected areas of tissue. To perform the spectral-diagnosis measurement, the probe will be gently placed on the surface of your skin. Each selected area of your skin will take about a few seconds to image. The probe will shine different types of light onto the skin, and it will collect the light that reflects from the skin surface. The light signals will be stored so that researchers can look at them. Preparing the lesion, imaging it, and collecting the light signals should take about 10-15 minutes per lesion.
After all of the imaging is over, you will have biopsies performed on the lesions that your study doctor has decided are in need of such treatment as part of your standard care.
After this clinic visit, your participation in the study will be over.
This is an investigational study. The imaging probe is not commercially available or FDA approved. At this time, it is being used in research only. Up to 150 patients will take part in this study. All will be enrolled at M. D. Anderson.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- University of Texas MD Anderson Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male or Female and over 18 years of age.
- Patients undergoing an examination of their skin
- Patients with a lesion(s) in one of the five categories: basal cell carcinoma, squamous cell carcinoma, pre-cancer lesions, pigmented lesions, and benign lesions
- Patients whose lesion also warrants a biopsy.
- Signed informed consent document.
Exclusion Criteria:
- Patients with absence of skin lesion(s) in one of the five categories.
- Patients whose identified lesion did not need a biopsy.
- Patients who did not sign the informed consent and agree to participate.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Spectral-Diagnosis
Method for noninvasive detection of cutaneous malignancies
|
The device collects two types of tissue spectra: i) laser-induced fluorescence spectra and ii) white light reflectance spectra.
This portable reflectance spectrofluorimeter collects spectra in a fraction of a second.
Light collection and delivery are achieved via an optical fiber probe.
The optical fiber probe is approximately 1 mm in diameter and 3 m long.
The same probe collects light emitted from the tissue and delivers it back to the instrument for spectral analysis.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Spectroscopic features of skin lesions in vivo
Time Frame: Preparing lesion, imaging it, and collecting the light signals should take about 10-15 minutes per lesion.
|
Preparing lesion, imaging it, and collecting the light signals should take about 10-15 minutes per lesion.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Michael Migden, MD, M.D. Anderson Cancer Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2006-0856
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Cancer
-
University of HawaiiVA Palo Alto Health Care SystemCompletedCancer, Other Than Non-melanoma Skin CancerUnited States
-
EnlundCompletedBreast Cancer | Skin Cancer | Colo-rectal CancerSweden
-
McMaster UniversityRecruitingSkin Cancer, Basal Cell Skin Cancer Skin Cancer, Non-Melanoma Skin Cancers - Squamous Cell Carcinoma Patient SatisfactionCanada
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)CompletedSkin Cancer PreventionUnited States
-
SciBase ABRecruitingKeratinocyte Skin CancerGermany
-
Rutgers, The State University of New JerseyCompleted
-
University of MichiganBlue Cross Blue Shield of Michigan FoundationCompletedSkin Cancer PreventionUnited States
-
Xoft, Inc.Eminence Clinical Research, Inc.UnknownNonmelanoma Skin CancerUnited States
-
OncoBeta TherapeuticsRecruitingNon-melanoma Skin CancerAustralia
-
University of Alabama at BirminghamNational Cancer Institute (NCI); National Institutes of Health (NIH)Active, not recruitingNon-melanoma Skin CancerUnited States
Clinical Trials on Spectral Diagnosis Probe
-
University of FloridaFlorida Probe CorporationCompletedPeriodontitis | Diagnoses DiseaseUnited States
-
Ottawa Hospital Research InstituteISBRG CorpRecruiting
-
University Hospital, BordeauxCompleted
-
Children's Hospital Medical Center, CincinnatiEnrolling by invitation
-
Cliniques universitaires Saint-Luc- Université...Completed
-
Philips (China) Investment CO., LTDWest China Hospital; Ruijin Hospital; Shanghai Changzheng HospitalTerminated
-
First Affiliated Hospital Xi'an Jiaotong UniversityNot yet recruiting
-
Centre Hospitalier Universitaire, AmiensRecruitingPain | Treatment | Episiotomy | Delivery Complication | Perineal ScarsFrance
-
Sheffield Teaching Hospitals NHS Foundation TrustCompletedPeriodontal DiseaseUnited Kingdom
-
Pelvital USA, Inc.Completed